• Necrotic Bone Involvement in an Adult Afflicted with B-Cell Precursor Acute Lymphoblastic Leukemia Mimicking Osteomyelitis: A Case Report

• ±èÇý¿ø(Kim Hae-Won) ±Ç¼ø¿ë(Kwon Soon-Yong) Á¤¿ä¼Á(Chong Yo-Sep) ¹ÚÁ¤¹Ì(Park Jeong-Mi)

• ´ëÇÑ¿µ»óÀÇÇÐȸÁö  2018³â 78±Ç 1È£ 30~34

• ATRA Ä¡·á¿¡ ÀÇÇØ À¯¹ßµÈ °ÍÀ¸·Î ÃßÁ¤µÇ´Â ±Þ¼º Àü°ñ¼ö¼º ¹éÇ÷º´ ȯÀÚÀÇ À½³¶ ±Ë¾ç 1¿¹

• Scrotal Ulcer Probably Induced by All-trans Retinoic Acid Therapy in a Patient with Acute Promyelocytic Leukemia

• ±è¿µÀç(Kim Young-Jae) ÀÌ¿ìÁø(Lee Woo-Jin) ¿øÁ¾Çö(Won Chong-Hyun) À强Àº(Chang Sung-Eun) ÃÖÁöÈ£(Choi Jee-Ho) À̹̿ì(Lee Mi-Woo)

• ´ëÇÑÇǺΰúÇÐȸÁö  2018³â 56±Ç 1È£ 80~81

• Spectrum of mitochondrial genome instability and implication of mitochondrial haplogroups in Korean patients with acute myeloid leukemia

• ±èÇý¶õ(Kim Hye-Ran) °­¹Î±¸(Kang Min-Gu) ÀÌ¿µÀº(Lee Young-Eun) ³ªº¸¶÷(Na Bo-Ram) (Noh Min-Seo) ¾ç½ÂÇö(Yang Seung-Hyun) ½ÅÁ¾Èñ(Shin Jong-Hee) (Shin Myun-Geun)

• Blood Research  2018³â 53±Ç 3È£ 240~249

• Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia

• (Al-Kahiry Waiel) (Tawfik Hadeel Said) (Sharshira Homam) (Ghanem Amal) (El-Gammal Maha) (Mikhael Irene Lewis)

• Blood Research  2018³â 53±Ç 3È£ 218~222

• Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations

• (Sharma Monica) (Tyagi Seema) (Tripathi Preeti) (Seth Tulika)

• Blood Research  2018³â 53±Ç 3È£ 205~209

• The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia

• ¹ÚÀ¯¹Ì(Park Yu-Mi) ÀÓÁø¼÷(Lim Jin-Sook) ±è¼±¿µ(Kim Seon-Young) ¼ÛÀÍÂù(Song Ik-Chan) ±Ç°èö(Kwon Kye-Chul) ±¸¼±È¸(Koo Sun-Hoe) ±èÁö¸í(Kim Ji-Myung)

• Blood Research  2018³â 53±Ç 3È£ 198~204

• Multifocal large aggregates of pseudo-Gaucher cells in chronic myeloid leukemia

• (Sharma Praveen) (Kumar Narender) (Varma Neelam)

• Blood Research  2018³â 53±Ç 3È£ 187~187

• Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia

• (Rajpal Sweta) (Nampoothiri Ram V.) (Sreedharanunni Sreejesh) (Parihar Mayur) (Malhotra Pankaj) (Varma Neelam)

• Blood Research  2018³â 53±Ç 2È£ 180~181

• Á¶Ç÷¼¼Æ÷ÀÌ½Ä ÈÄ Àç¹ßÇÑ ¹éÇ÷º´ ȯÀÚÀÇ Çô Á¾¹°

• Tongue Mass Arising after Hematopoietic Cell Transplantation and Leukemia Relapse

• ÃÖ¼ºÈ¯(Choi Sung-Hwan) ¹Ú½½¸¶·Î(Park Slmaro) ±èÇö½Ç(Kim Hyun-Sil) Á¶Àº¾Ö(Cho Eun-Ae)

• ´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö  2018³â 42±Ç 4È£ 95~98

• ±Þ¼ºÀü°ñ¼ö±¸¼º¹éÇ÷º´ ȯÀÚ¿¡¼­ all-trans retinoic acid (ATRA)ÀÇ ºÐÈ­ÁõÈıº ¹ß»ý°ú À§ÇèÀÎÀÚ ºÐ¼®

• Incidence and Risk Factors for All-Trans Retinoic Acid-Induced Differentiation Syndrome in Acute Promyelocytic Leukemia

• Á¤°í¿î(Jung Go-Un) ¹Ú¾Ö·É(Park Ae-Ryoung) ±è¼øÁÖ(Kim Soon-Joo) ³ªÇö¿À(La Hyen-O) ÀÌÁ¤¿¬(Rhie Sandy Jeong)

• º´¿ø¾à»çȸÁö  2018³â 35±Ç 1È£ 39~47

• Insect Bite-Like Reaction with Bullous Lesions Mimicking Bullous Pemphigoid in a Patient with Chronic Lymphocytic Leukemia

• ±èÁöÀº(Kim Jee-Eun) ±è¼öÂù(Kim Soo-Chan)

• Annals of Dermatology  2018³â 30±Ç 4È£ 468~472

• ¼Ò¾Æ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´¿¡¼­ °üÇØÀ¯µµ ¿ä¹ý Áß PosaconazoleÀÇ ¿¹¹æÀû Ç×Áø±Õ Ä¡·á

• Posaconazole for Prophylaxis of Fungal Infection in Pediatric Patients with Acute Myeloid Leukemia undergoing Induction Chemotherapy

• ±è½Â¹Î(Kim Seung-Min) ÀÌÀ±¼±(Ree Yoon-Sun) ±èÀç¼Û(Kim Jae-Song) ±è¼öÇö(Kim Soo-Hyun) ¼ÕÀº¼±(Son Eun-Sun) À¯Ã¶ÁÖ(Lyu Chuhl-Joo)

• Çѱ¹ÀÓ»ó¾àÇÐȸÁö  2018³â 28±Ç 3È£ 181~187

• ¼Ò¾Æ ¹éÇ÷º´ ȯÀÚ¿¡¼­ Ä¡·á Áß ¹ß»ýÇÑ ¿¡µåÇÏÀÓ-ü½ºÅÍ º´

• A Case of Erdheim-Chester Disease Developed during Treatment of Leukemiain a Child

• È«ÁØÇ¥(Hong Joon-Pyo) ¾È¿ø±â(Ahn Won-Ki) ÀÓÁÖ¿¬(Lim Joo-Yeon) Á¤Á¶Àº(Jung Jo-Eun) Çѽ¹Î(Hahn Seung-Min) ÇÑÁ¤¿ì(Han Jung-Woo) À¯Ã¶ÁÖ(Lyu Chuhl-Joo)

• Clinical Pediatric Hematology-Oncology  2018³â 25±Ç 1È£ 66~70

• °©»ó¼±¾Ï ȯÀÚ¿¡¼­ ¹æ»ç¼º¿ä¿Àµå Ä¡·á ÈÄ ¹ß»ýÇÑ ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ 2¿¹

• Chronic Myeloid Leukemia Following Radioactive Iodine Treatment for Thyroid Cancer: Two Case Reports and a Literature Review

• ¹ÚÇØ¿­(Park Hae-Yeol) ÃÖ¼ºÀº(Choi Sung-Eun) À¯¿µÈÆ(Ryu Yong-Hoon) ÀåÇ×¼®(Chang Hang-Seok) ¹ÚÁ¤¼ö(Park Cheong-Soo) ÀÌ°æÈ­(Lee Kyoung-Hwa) ±èÀ¯¸®(Kim Yu-Ri)

• ´ëÇѳ»°úÇÐȸÁö  2016³â 91±Ç 1È£ 70~74

• ¼Ò¾Æ ¹éÇ÷º´ ȯÀÚÀÇ µ¿Á¾ Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä Àüóġ·Î¼­ Àü½Å¹æ»ç¼± Á¶»ç Æ÷ÇÔ±º°ú ºñÆ÷ÇÔ±ºÀÇ ºñ±³

• Comparison of total body irradiation-based or non-total body irradiation-based conditioning regimens for allogeneic stem cell transplantation in pediatric leukemia patients

• ±è»óÁ¤(Kim Sang-Jeong) Çѵ¿±Õ(Han Dong-Kyun) ¹éÈñÁ¶(Baek Hee-Jo) ±èµ¿¿¬(Kim Dong-Yeon) ³²ÅñÙ(Nam Taek-Keun) ȲÅÂÁÖ(Hwang Tai-Ju) ±¹ÈÆ(Kook Hoon)

• Korean Journal of Pediatrics  2010³â 53±Ç 4È£ 538~547

• Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide

• ÀÌÁöÇö(Lee Ji-Hyun) ÃÖÁö¹Î(Choi Ji-min) ±Ç°æ¾Æ(Kwon Kyung-A) À̼ö(Lee Suee) ¿À¼º¿ë(Oh Sung-Yong) ±ÇÇõÂù(Kwon Hyuk-Chan) ±èÈ¿Áø(Kim Hyo-Jin) ÇÑÁø¿µ(Han Jin-Young) ±è¼ºÇö(Kim Sung-Hyun)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  2010³â 45±Ç 2È£ 102~108

• °Ë»ç Àü ±³À°°ú °Ç°­ °è¾àÀÌ ¹éÇ÷º´ ¾Æµ¿ÀÇ Ã´¼ö °Ë»ç ¼øÀÀ Á¤µµ¿Í ºÒ¾È¿¡ ¹ÌÄ¡´Â È¿°ú

• Effect of Preeducation and Health Contract on Adaptability and Anxiety during Spinal Puncture in Children with Leukemia

• ¹ÚÈ£¶õ(Park Ho-Ran) ±¸Çö¿µ(Koo Hyun-Young) Á¶¹Ì³ª(Jo Mi-Na)

• ¾Æµ¿°£È£ÇÐȸÁö  2006³â 12±Ç 4È£ 462~469

• Transforming Growth Factor-beta1ÀÌ ¾Ç¼º¸²ÇÁÁ¾°ú ¹éÇ÷º´ ¼¼Æ÷ÁÖÀÇ ¼ºÀå, c-myc mRNA ¹ßÇö, TelomeraseÈ°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect on Cell Growth, c-myc mRNA Expression and Telomerase Activity by Transforming Growth Factor-beta1 in Malignant Lymphoma and Leukemia Cell Line

• ÀÌÁÖÈ£(Li Zhu-Ho) À̹ÌÀÚ(Lee Mi-Ja) ÀüÈ£Á¾(Jeon Ho-Jong) È«ÂùÇ¥(Hong Chan-Pyo) ¹ÚÄ¡¿µ(Park Chi-Young) Á¤ÃáÇØ(Chung Choon-Hae)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  2005³â 40±Ç 3È£ 149~158

• ¼Ò¾Æ±â ±Þ¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´¿¡¼­ E2A-PBX1 °Ë»ö¿¡ ÀÇÇÑ ¹Ì¼¼ÀÜÁ¸ ¹éÇ÷º´ÀÇ ÀÇÀÇ ¹× Áö¿¬°­È­¿ä¹ýÀÇ È¿°ú

• The Implications of E2A-PBX1 Positivity and Effect of Delayed Intensification Chemotherapy in t(1;19)-positive Childhood Acute Lymphoblastic Leukemia

• ¼­Á¾Áø(Seo Jong-Jin) ±èÀºÁ¤(Kim Eun-Jung) ¹ÚÁØÀº(Park Jun-Eun) ¼­À»ÁÖ(Seo Eul-Ju) ÁöÇö¼÷(Chi Hyun-Sook) ¹®Çü³²(Moon Hyung-Nam) ±èÅÂÇü(Ghim Thae-T.)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  2001³â 36±Ç 1È£ 60~70

• ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ ȯÀÚ¿¡¼­ Idarubicin/BH-AC º¹ÇÕ°üÇØÀ¯µµ¿ä¹ýÀÇ Ä¡·á È¿°ú ¹× ¿¹ÈÄ ºÐ¼®

• Therapeutic Effect and Prognostic Analysis of Induction Chemotherapy with Idarubicin/BH-AC in Acute Myelogenous Leukemia

• ÀÌÁ¦Áß/Je Jung Lee Á¤ÀÍÁÖ/¾ç´öȯ/Á¶»óÈñ/¾çÅ¿µ/¹ÚÇüõ/¹Ú¹«¸²/±èÇüÁØ/Ik Joo Chung/Duc Hwan Yang/Sang Hee Cho/Tae Young Yang/Hyeong Cheon Park/Moo Rim Park/Hyeoung Joon Kim

• ´ëÇÑÇ÷¾×ÇÐȸÁö  2000³â 35±Ç 2È£ 109~116

• ±Þ¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ ȯ¾Æ¿¡¼­ Ç׾Ͽä¹ý¿¡ µû¸¥ Ç÷¾× ÀÀ°í°èÀÇ º¯µ¿ ¹× Ç×Æ®·Òºó ¥² º¸Ãæ¿ä¹ýÀÇ È¿°ú

• Hemostatic Changes and Effect of Antithrombin ¥² Replacement Therapy in Children with Acute Lymphoblastic Leukemia

• ÃÖÁ¤¾Æ ÀÓ¿µÅ¹

• ¼Ò¾Æ°ú  1999³â 42±Ç 11È£ 1567~1573

• ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´¿¡¼­ BHAC¿Í IdarubicinÀ» ÀÌ¿ëÇÑ °üÇØÀ¯µµ¿ä¹ýÀÇ È¿°ú ¹× °üÇØÈÄ Ä¡·á¹æħ¿¡ µû¸¥ Àå±â »ýÁ¸À²ÀÇ ºñ±³

• Effects of Induction Chemotherapy with BHAC Plus Idarubicin on Long-term Survival for Patients with Acute Myelogenous Leukemia according to Different Postremission Strategies

• ±èÃáÃß/Chun Choo Kim ÀÌÁ¾¿í/±èÈñÁ¦/±è±â¿ø/¹Ú¼öÁ¤/¼­Á¤°ï/¹Îâ±â/¾öÇö¼®/È«¿µ¼±/¹Î¿ì¼º/½Å¿Ï½Ä/±èµ¿Áý/Jong Wook Lee/Hee Je Kim/Ki Won Kim/Soo Jeong Park/Jung Gon Suh/Chang Ki Min/Hyeon Seok Eom/Young Seon Hong/Woo Sung Min/Wan Shik Shin/Dong Jip Kim

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1999³â 34±Ç 2È£ 317~325

• µ¿Á¾ °ñ¼öÀÌ½Ä ÈÄ Àç¹ßÇÑ ¹éÇ÷º´¿¡¼­ °ø¿©ÀÚ ¹éÇ÷±¸ ÁÖÀÔ : À̽ÄÆí´ë¹éÇ÷º´È¿°ú¿¡ °üÇÑ ´Ù±â°ü Àӻ󿬱¸

• Donor Leukocyte Infusion as Treatment for Relapsed Leukemia after Allogeneic Bone Marrow Transplantation : Graft-versus-Leukemia Effect

• À̼®/Seok Lee ¹Ú¼±¾ç/±èº´±¹/ÀÌÈ«±â/¹ÚÂùÇü/³²µ¿±â/±èȿö/ÀÌ°æÈñ/Çö¸í¼ö/¿Àµµ¿¬/±è¿µÃ¶/À̼ø³²/¼ºÁÖ¸í/Seon Yang Park/Byoung Kook Kim/Hong Ghi Lee/Chan Hyung Park/Dong Ki Nam/Hugh Chul Kim/Kyung Hee Lee/Myung Soo Hyun/Do Yeun Oh/Young Cheol Kim/Soon Nam Lee/Chu Myong Seong

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1999³â 34±Ç 2È£ 252~262

• ±Þ¼º Àü°ñ¼ö¼º¹éÇ÷º´¿¡¼­ All-trans-retinoic Acid(ATRA) °üÇØÀ¯µµ ÈÄ º¹ÇÕÇ×¾ÏÈ­Çпä¹ýÀÇ È¿°ú

• The Long-term Effect of Induction Chemotherapy With All-trans-retinoic Acid(ATRA) Followed by Consolidation Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia

• Á¤ÁÖ¿µ ±èÇбÕ/¹æ¼ö¹Ì/À¯¿µÁø/À̹®Èñ/¾ÈÁø¼®/ÀÌÁ¾ÅÂ/ÀÓ¼®¾Æ/¹Ú¼±¾ç

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1999³â 34±Ç 1È£ 80~89

• °ñ¼öÀ̽ÄÀ» ½ÃÇà¹ÞÀº ¹éÇ÷º´È¯¾Æ¿¡¼­ Àü½Å¹æ»ç¼±Á¶»ç°¡ Ç÷Áß Leptin³óµµ¿¡ ¹ÌÄ¡´Â ´Ü±â°£ÀÇ ¿µÇâ

• Acute Effects of Total Body Irradiation on Serum Leptin Concentration in Children with Acute Leukemia Undergoing Bone Marrow Transplantation

• ±è°æÇö À̶õ ±èÁøö ÀÌÁ¾°Ç

• ´ëÇѼҾƳ»ºÐºñÇÐȸÁö  1999³â 4±Ç 1È£ 88~93

• Àü½Å ¹æ»ç¼± Á¶»ç¿Í cyclophosphamide Åõ¿© ¼ø¼­°¡ ¼ºÀÎÇü ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâ

• The Effect of Sequence between Total Body Irradiation and Cyclophosphamide in Acute Myeloid Leukemia

• ÃÖÀϺÀ/Ihl Bohng Choi ±èÀξÆ/ÀåÁö¿µ/°­±â¹®/°­¿µ³²/¹Ú¼öÁ¤/¼­Á¤°ï/±èÈñÁ¦/¹Îâ±â/ÀÌÁ¾¿í/¹Î¿ì¼º/±èÃáÃß/in Ah Kim/Ji Young Jang/Ki Mun Kang/Young Nam Kang/Soo Jeong Park/Jung Gon Suh/Hee Je Kim/Chang Ki Nin/Jong Wook Lee/Woo Sung Min/Chun Choo Kim

• ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸÁö  1998³â 3±Ç 2È£ 163~171

• All-trans Retinoic Acid°¡ ±Þ¼ºÀü°ñ¼ö¼º¹éÇ÷º´ÀÇ °üÇØÀ¯µµ¿Í Ç÷¾×ÀÀ°íÀå¾Ö¿¡ ¹ÌÄ¡´Â È¿°ú

• Effect of All-Trans Retionic Acid(ATRA) on the Remission Induction and Coagulopathy in Acute Promyelocytic Leukemia(APL)

• ÀÌö¿ø À̵µ»ó ¹®¼ºÃ¶ À±ÁöÇý

• ´ëÇѳ»°úÇÐȸÁö  1997³â 53±Ç 2È£ 199~206

• ¼ºÀÎ ±Þ¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´¿¡¼­ °­È­µÈ °üÇØÀ¯µµ¿ä¹ýÀÇ Ä¡·áÈ¿°ú

• Effect of Treatment with Intensified Induction Regimen in Adult Acute Lymphocytic Leukemia

• ¼®ÁØÈ£ ÀÌ°æÈñ Çö¸í¼ö

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1997³â 32±Ç 3È£ 376~387

• ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´¿¡¼­ Ara-C, Daunorubicin È­Çпä¹ýÀÇ Ä¡·á È¿°ú

• Effect of Cytosine Arabinoside and Daunorubicin(AD) Combination Chemotherapy in Acute Myelogenous Leukemia

• °­¿µ¼÷ Á¤Çö½Ä/±èż®/À±Çü¼±/±èµæÁ¶/À±Á¤È£/À̼º±¤/ÁöÇö±Ô/³²±ÍÇö

• ´ëÇѾÏÇÐȸÁö  1997³â 29±Ç 1È£ 160~170

• ÀÚ±âÈ¿´É¤ýÈñ¸ÁÁõÁøÇÁ·Î±×·¥ÀÌ ÀڱⰣȣ ÇàÀ§¿Í »îÀÇ Áú¿¡ ¹ÌÄ¡´Â È¿°ú -¹éÇ÷º´ ȯÀÚ Áß½É-

• Effects of a Program to Promote Self-Efficacy and Hope on the Self-Care Behaviors and the Quality of Life in Patients with Leukemia

• ¿Àº¹ÀÚ Å¿µ¼÷ ¾öµ¿Ãá ÀÌÀº¿Á

• Journal of Korean Academy of Nursing  1997³â 27±Ç 3È£ 627~638

• ³ë·ÉÃþ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´¿¡¼­ °üÇØÀ¯µµ¿ä¹ýÈÄ Á¶Ç÷ÃËÁø ÀÎÀÚÀÇ È¿°ú

• The Effect of Hematopoietic Growth Factors after Induction Chemotherapy in Elderly Patients with Acute Myelogenous Leukemia

• À̼®/Seok Lee ¹ÎÀ¯È«/¼­ÇüÂù/Á¤¼Ò¿µ/ÇÑÁö¼÷/°íÀ±¿õ/Yoo Hong Min/Hyung Chan Suh/So Young Chong/Jee Sook Hahn/Yun Woong Ko

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1996³â 31±Ç 3È£ 427~436

• ¼ºÀÎ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´¿¡¼­ °ú¸³±¸ ¹× °ú¸³±¸- ´ë½Ä¼¼Æ÷ Áý¶ôÃËÁøÀÎÀÚ°¡ °¨¿°Áõ¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect of Granulocyte or Granulocyte/MacroPhage Colony-Stimulating Factors on Infection in Adult Acute Myeloid Leukemia

• ±è¼ºÃ¶/Seong Cheol Kim ¹ÎÀ¯È«/À̼®/Á¤¼Ò¿µ/À¯³»Ãá/ÇÑÁö¼÷/°íÀ±¿õ/Yoo Hong Min/Seok Lee/Soh Young Chong/Nae Choon Yoo/Jee Sook Hahn/Yun Woong Ko

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1996³â 31±Ç 2È£ 275~288

• ¾óÀ½À» ÀÌ¿ëÇÑ ±¸°­°£È£°¡ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ ±¸°­»óÅ¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect of the Ice-Applied Mouth Care on the Oral Cavity in Patients with Acute Myelogenous Leukemia

• ±è°æ¹Ì(Kim Kyung-Mi)

• È£½ºÇǽº±³À°¿¬±¸¼ÒÁö  1996³â 1±Ç 1È£ 18~23

• ±Þ¼º Àü°ñ¼ö±¸¼º¹éÇ÷º´¿¡¼­ All-trans Retinoic AcidÀÇ È¿°ú

• The Effect of All-trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia

• À̼®/Seok Lee ¹ÎÀ¯È«/Á¤¼Ò¿µ/ÇÑÁö¼÷/°íÀ±¿õ/Yoo Hong Min/So Young Chong/Jee Sook Hahn/Yun Woong Ko

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1995³â 30±Ç 3È£ 431~440

• ±Þ¼º °ñ¼ö¼º¹éÇ÷º´¿¡¼­ Stem Cell Factor°¡ CD34⁺¼¼Æ÷ÀÇ Áõ½Ä ¹× IL-1¥â, IL-4, TNF-¥áÀÇ ºÐºñ¿¡ ¹ÌÄ¡´Â È¿°ú

• The Effect of Stem Cell Factor on Secretion of Interleukin-l¥â, Interleukin-4 and Tumor Necrosis Factor-¥á from CD34⁺ Acute Myelogenous Leukemia Blast Cells

• À̼®/Seok Lee ¹ÎÀ¯È«/Á¤¼Ò¿µ/ÇÑÁö¼÷/°íÀ±¿õ/Yoo Hong Min/So Young Chong/Jee Sook Hahn/Yun Woong Ko

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1995³â 30±Ç 3È£ 415~429

• Àå±â°£ »ýÁ¸ÇÑ ±Þ¼º ¸²ÇÁ±¸¼º¹éÇ÷º´ ȯ¾Æ¿¡¼­ÀÇ ¿¹¹æÀû ÁßÃ߽Űæ°è Ä¡·á°¡ ½Å°æÁ¤½Å±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effects of Central Nervous System Irradiation on Neuropsychologic Functioning in Longterm Survivours of Childhood Acute Lymphoblastic Leukemia

• ÃÖÁöÀº ½ÅÈñ¿µ/±èÀοø/¿¬°æ¸ð/äÀοµ/Á¶¼öö/Ȳ¿ë½Â/¾ÈÈ¿¼·

• ´ëÇѾÏÇÐȸÁö  1995³â 27±Ç 2È£ 303~315

• ¼Ò¾Æ ±Þ¼º ¹éÇ÷º´¿¡¼­ Ç×¾ÏÈ­Çпä¹ý ÈÄ È£Áß±¸ °¨¼Ò½Ã ¼¼Æ÷Ãæ½Çµµ¿¡ µû¸¥ rhG-CSF¹× rhGM-CSFÀÇ È¿°ú

• Effect of Recombinant Human Granulocyte Colony-stimulating Factor(rhG-CSF) and Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor(rhGM-CSF) in Children with Acute Leukemia Receiving Chemotherapy according to Bone MarrowCellularity

• Á¤¼ÒÁ¤(Chung So-Chung) À¯Ã¶ÁÖ(Lyu Chuhl-Joo) ¿À½Âȯ(Oh Seung-Hwan) ¾çâÇö(Yang Chang-Hyun) ±è±æ¿µ(Kim Kil-Young)

• Clinical Pediatric Hematology-Oncology  1995³â 2±Ç 2È£ 281~289

• ¼Ò¾Æ ±Þ¼º Àü°ñ¼ö¼º ¹éÇ÷º´¿¡¼­ All-Trans Retinoic»êÀÇ °üÇØÀ¯µµ È¿°ú

• Effects of All-Trans Retinoic Acid for Childhood Acute Promyelocytic Leukemia in Remission Induction

• ÀÌÁ¾·Ï À§¼º½Å ±èÁøö

• Clinical Pediatric Hematology-Oncology  1995³â 2±Ç 2È£ 266~271

• ¾óÀ½À» ÀÌ¿ëÇÑ ±¸°­°£È£°¡ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ ±¸°­»óÅ¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect of the Ice-Applied Mouth Care on the Oral Cavity in Patients with Acute Myelogenous Leukemia

• ±è°æ¹Ì

• °¡Å縯´ëÇÐÀÇÇÐºÎ³í¹®Áý  1994³â 47±Ç 3È£ 1331~1336

• ¼ºÀÎ ±Þ¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´¿¡¼­ Vincristine, Prednisolone, Daunorubicin, L-asparaginase 4Á¦ º¹ÇÕÈ­Çпä¹ýÀÇ Ä¡·áÈ¿°ú

• Effect of Treatment with Vincristine, Prednisolone, Daunorubicin, and L-aspara- ginase in Adult Acute Lyrnphocytic Leukemia

• À¯¿ë±Ô(You Yong-Kyu) ÀÌÈ£¼ö(Lee Ho-Soo) ±èÁÖÈ£(Kim Joo-Ho) ¹ÚÁØ¿µ(Park Jun-Young) ¿øÁ¾È£(Won Jong-Ho) È«´ë½Ä(Hong Dae-Sik) ¹ÚÈñ¼÷(Park Hee-Sook)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1994³â 29±Ç 3È£ 287~297

• ¼Ò¾Æ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ È­Çпä¹ý¿¡ µû¸¥ È£Áß±¸ °¨¼Ò¿¡ ´ëÇÑ Filgrastim(rhG-CSF)ÀÇ È¿°ú

• Effect of Filgrastim(rhG-CSF) on Chemotherapy Induced Neutropenia in Pediatric Acute Myelogenous Leukemia Patients

• ½ÅÈñ¿µ(Shin Hee-Young) ¹Ú°æ´ö(Park Kyung-Duk) ÇϼºÈÆ(Ha Seong-Hoon) ±¸È«È¸(Koo Hong-Hoe) ¾ÈÈ¿¼·(Ahn Hyo-Seop)

• ´ëÇѾÏÇÐȸÁö  1994³â 26±Ç 1È£ 136~143

• ¼Ò¾Æ ±Þ¼º ºñ¸²ÇÁ±¸¼º ¹éÇ÷º´¿¡¼­ Idarubicin°ú Cytosine Arabinoside·Î °üÇØÀ¯µµÈÄ¿¡ °ú¸³±¸ Áý¶ôÀÚ±ØÀÎÀÚÀÇ È¿°ú

• Effect of Recombinant Human Granulocyte Colony-Stimulating Factor(rhG-CSF) in Children with Acute Nonlymphocytic Leukemia Recieving Induction Chemotherapy with Idarubicin and Cytosine Arabinoside

• ±èÇб⠱è±æ¿µ/±èÈï½Ä/½Å»ó¸¸/½ÅÈñ¿µ/¾Èµ·Èñ/¾ÈÈ¿¼·/¿À½Âȯ/À¯Ã¶ÁÖ

• Çѱ¹BRMÇÐȸÁö  1994³â 4±Ç 1È£ 17~24

• ¼Ò¾Æ ±Þ¼º ºñ¸²ÇÁ±¸¼º ¹éÇ÷º´¿¡¼­ Idarubicin°ú Cytosine arabinoside·Î °üÇØÀ¯µµÈÄ¿¡ °ú¸³±¸-Áý¶ôÀÚ±ØÀÎÀÚÀÇ È¿°ú -ÀüÇâÀû ÀÌÁß ºñ±³ÀÇ ´Ù±â°ü Àӻ󿬱¸-

• Effect of Recombinant Human Granulocyte Colons-Stimulating Factor(rhG-CBF) in Children with Acute Nonlymphocytic Leukemia Recieving Induction Chemotherapy with Idarubicin and Crtosine Arabinoside - Prospective, Randomized, Controlled MulticenterStudy-

• ±èÇб⠱è±æ¿µ/±èÈï½Ä/½Å»ó¸¸/½Åȸ¿µ/¾Èµ·È¸/¾ÈÈ¿¼·/¿À½Âȯ/À¯Ã¶ÁÖ

• Clinical Pediatric Hematology-Oncology  1994³â 1±Ç 1È£ 24~31

• °ú¸³±¸-´Ü±¸ Áý¶ôÃËÁøÀÎÀÚ°¡ ±Þ¼º¹éÇ÷º´ °ñ¼ö¼¼Æ÷ Àå±â¹è¾ç¿¡ ¹ÌÄ¡´Â ¿µÇâ

• The Effects of GM-CSF on the Long-Term Bone Marrow Cultures in Acute Leukemia

• ¹ÎÀ¯È« °íÀ±¿õ À̼±ÁÖ ÇÑÁö¼÷ °íÀ±¿õ(Ko Yun-Woong) À̼±ÁÖ(Lee Sun-Ju) ÇÑÁö¼÷(Hahn Jee-Sook)

• ´ëÇѳ»°úÇÐȸÁö  1993³â 44±Ç 3È£ 327~346

• ±Þ¼º ¸²ÇÁ±¸¼º ¹éÇ÷º´ ȯ¾Æ¿¡¼­ °æ½ÃÀûÀ¸·Î °üÂûÇÑ ¸»ÃÊÇ÷ Ç÷±¸ ¼ö°¡ Ä¡·á ¹× ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect of Peripheral Blood Cell Counts during Remission Induction and Maintenance Therapy on the Prognosis and Therapy of Childhood Acute Lymphoblastic Leukemia

• ±èÁØȸ/Jun Hee Kim °íµ¿ÈÆ/¹®´ë±Ù/±¹ÈÆ/ȲÅÂÁÖ/Dong Hoon Ko/Dae Keun Moon/Hoon Kook/and Tai Ju Hwang

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1993³â 28±Ç 1È£ 81~88

• ±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ È­Çпä¹ý¿¡¼­ Granulocyte Colony-Stimulating Factor(Filgrastim)ÀÇ È¿°ú

• The Effect of Granulocyte Colony-Stimulating Factor in Chemotherapy of Acute Myelogenous Leukemia

• Á¤º´Ãµ/Byung Chun Chung °ûµ¿¼®/ÃÖÁ¤ÀÏ/ÀÓÁ¾¿ì/À̱Ժ¸/Dong Suk Kwok/Jung Il Choi/Jong Woo Lim/Kyu Bo Lee

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1993³â 28±Ç 1È£ 21~30

• ±Þ¼º°ñ¼ö¼º¹éÇ÷º´¿¡ ´ëÇÑ °üÇØÀ¯µµÈ­Çпä¹ý ÈÄÀÇ Granulocyte Colony-stimulating FactorÀÇ È¿°ú

• Effects of Granulocyte Colony-stimulating Factor after Induction Chemotherapy for Acute Myelogenous Leukemia

• À±È­Áß ÃÖÁö¿µ/ÀüÀÇ°Ç/±æÁØ¿µ/Á¶´ö¿¬/±è»ï¿ë

• Ãæ³²ÀÇ´ëÀâÁö  1993³â 20±Ç 2È£ 157~164

• ±Þ¼º ÀÓÆı¸¼º ¹éÇ÷º´ÀÇ ³úô¼ö¾×³» Àç¹ß½Ã °£ÇæÀûÀÎ ÀüÁßÃ߽Űæ°è ¹æ»ç¼±Á¶»ç ¹× ô¼ö°­³» È­Çпä¹ýÀÇ È¿°ú

• The Effect of Intermittent Craniospinal Irradiation and Intrathecal Chemotherapy for Overt Meningeal Leukemia

• ±èÀξÆ(Kim In-Ah) ÃÖÀϺÀ(Choi Ihl-Bhong) Á¤¼ö¹Ì(Chung Su-Mi) ½Å°æ¼·(Shinn Kyung-Sub)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1993³â 11±Ç 2È£ 403~409

• Idarubicin°ú Ara-C·Î °üÇØÀ¯µµ ¿ä¹ýÀ» ½Ç½ÃÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ ȯÀÚ¿¡¼­ Granulocyte Colony-Stimulating Factor (G-CSF)ÀÇ È¿°ú

• Effect of Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Acute myelogenous Leukemia Receiving Intensive Induction Chemotherapy with Idarubicin and Ara-C

• ÀÌÁ¾¿í ±èµ¿¿í/±èº´±¹/±èÃáÃß/¹Î¿ì¼º/¹ÚÀçÈÄ/¹ÚÁ¾¿ø/¹ÚÈñ¼÷/¼ÕâÇÐ

• Çѱ¹BRMÇÐȸÁö  1993³â 3±Ç 1È£ 99~106

• ±Þ¼º ¹éÇ÷º´ ȯÀÚ¿¡¼­ Ç×¾ÏÁ¦ Ä¡·á·Î À¯¹ßµÇ´Â ¿À½É°ú ±¸Åä¿¡ ´ëÇÑ OndansetronÀÇ È¿°ú

• Effects of Ondansetron in the Prevention of Nausea and Vomiting Associated with Chemotherapy in Acute Myelocytic Leukemia

• ¹Î¿ì¼º ÁøÁ¾·ü/ÇÑÄ¡È­/¹ÚÁ¾¿ø/±èÃáÃß/±èµ¿Áý

• ´ëÇѾÏÇÐȸÁö  1992³â 24±Ç 2È£ 288~292

• ±Ø½ÉÇÑ ¹éÇ÷±¸ Áõ´ÙÁõÀÌ µ¿¹ÝµÈ ¼ºÀÎ ¹éÇ÷º´¿¡ À־ ÀÀ±Þ µÎ°³ºÎ ¹æ»ç¼± Á¶»çÀÇ È¿°ú

• Emergency Cranial Irradiation Effects in Adult Leukemia with Extremely High Leukocytosis

• ¹Ú½ÂÈ£(Park Seoung-Ho) Á¶¹®ÁØ(Cho Moon-June) ±è»ï¿ë(Kim Sam-Yong)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1992³â 10±Ç 2È£ 255~259

• ¼Ò¾Æ ±Þ¼º ÀÓÆı¸¼º ¹éÇ÷º´¿¡¼­ ¿¹¹æÀû Àü³ú ¹æ»ç¼±Á¶»çÀÇ È¿°ú

• Effect of Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia in Children

• ±èÀÏÇÑ(Kim Il-Han) ÃÖµÎÈ£(Choi Doo-Ho) ±èÁ¾ÈÆ(Kim Jong-Hoon) ÇϼºÈ¯(Ha Sung-Whan) ¹ÚÂùÀÏ(Park Charn-Il) ¾ÈÈ¿¼·(Ahn Hyo-Seop)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1989³â 7±Ç 2È£ 269~277

• ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ ȯÀÚ¿¡¼­ È­Çпä¹ý¿¡ º´¿ëµÈ °¨¸¶ÀÎÅÍÆä·ÐÀÇ È¿°ú

• The Additive Effect of Recombinant r-Interferon on the Chronic Myelogenous Leukemia Patients Under Conventional Chemotherapy

• ¹ÚÁ¾¿ø(Park Chong-Won) ¹ÚűÙ(Park Tae-Keun) ±èÁÖö(Kim J.-C.) ÇÑÄ¡È­(Han Chi-Hwa) ±èÃáÃß(Kim Choon-Choo) ±èµ¿Áý(Kim Dong-Jip)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1988³â 23±Ç 2È£ 373~379

• ±Þ¼º Àü°ñ¼ö±¸¼º ¹éÇ÷º´¿¡ º´¹ßÇÑ ÆÄÁ¾¼º Ç÷°ü³» ÀÀ°íº´Áõ¿¡¼­ Gabexate mesilate(FOY^®)ÀÇ ÀÓ»óÈ¿°ú

• The Effect of Gabexate Mesilate (FOY^®) on the Treatment of Disseminated Intravascular Coagulation Associated with Acute Promyelocytic Leukemia

• ÀÌÈ«º¹/H B Lee ±èº´±¹/ÀÌ¿µ¿­/±è½ÂÅÃ/Çã´ë¼®/¹Ú¼±¾ç/±è³ë°æ/B K Kim/Y Y Lee/S T Kim/D S Huh/S Y Park/N K Kim

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1987³â 22±Ç 1È£ 37~42

• ³­Ä¡¼º¼ºÀα޼º °ñ¼ö¼º ¹éÇ÷º´¿¡¼­ 4'-(9-Acridinylarno)Methanesulfon-rn-Anisidide (AMSA)ÀÇ È¿°ú

• The Effect of 4'- (9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA.) in the Treatment of Refractory Adult Acute Myeloid Leukemia

• ¼­Àç¿­/J T Suh ÃÖ¸í±Ô/½Â±â¹è/¹ÚÁ¾¿ø/±èÃáÃß/±èµ¿Áý/GaleR.P/M G Choi/K B Seung/C W Park/C C Kim/D J Kim/R P Gale

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1984³â 19±Ç 1È£ 39~44

• ±Þ¼º°ñ¼ö¼º¹éÇ÷Çü¿¡ ´ëÇÑ TAD º¹ÇÕÈ­Çпä¹ýÀÇ Ä¡·áÈ¿°ú

• Effect of TAD Combination Chemotherapy in Acute Myeloid Leukemia

• ÀÌ¿µ±Ô(ì°çÈФ)/Y.K. Lee ÃÖÀÏ¿µ(õËìéç¶)/I.Y. Choi

• ´ëÇÑÇ÷¾×ÇÐȸÁö  1982³â 17±Ç 2È£ 141~147